Is Dennis Purcell Trimming His Position In Roka Bioscience Inc. (ROKA) Too Early?
Dennis Purcell’s Aisling Capital trimmed its position in Roka Bioscience Inc. (NASDAQ:ROKA) by 246,049 shares in July.
Hedge Fund - Aisling Capital
News, Interviews, and Investor Letters
- First
- << Previous
- 11 - 15
Aisling Capital and OrbiMed Advisors See Value in This Canadian Pharmaceutical Company, Disclosing New Positions
Dennis Purcell’s Aisling Capital and Samuel Isaly’s OrbiMed Advisors have initiated new positions in Cynapsus Therapeutics Inc (NASDAQ:CYNA). In new filings with the U.S.
Aisling Capital Reduces Stake in Cempra Inc (CEMP)
Dennis Purcell's Aisling Capital recently filed an amended 13D with the SEC disclosing a reduced stake in Cempra Inc (NASDAQ:CEMP).
Esperion Therapeutics Inc (ESPR), Cempra Inc (CEMP), Zeltiq Aesthetics Inc (ZLTQ): Aisling Capital's Winning Plays in Small-Cap Healthcare Stocks
On Tuesday, Esperion Therapeutics Inc (NASDAQ:ESPR)'s stock closed the trading section as one of the market leaders, ending the day up by 29%.
Aisling Capital Reported 12.7% Activist Stake in $ZLTQ
Aisling Capital announced 4.17 million shares in Zeltiq Aesthetics, Inc. (ZLTQ), corresponding to a 12.7% activist stake.
- First
- << Previous
- 11 - 15